GE
60
5
APA
30
5
DUK
49
4
WMB
58
3
R
55
-2
NTAP
58
3
FITB
36
3
DHI
36
3
PM
49
8
CMCSA
49
3
SO
48
6
HPE
48
2
CVS
27
2
AON
25
4
IR
46
3
KIM
58
2
DIS
70
2
SCHW
40
3
ED
39
8
NKE
36
2
GE
60
5
APA
30
5
DUK
49
4
WMB
58
3
R
55
-2
NTAP
58
3
FITB
36
3
DHI
36
3
PM
49
8
CMCSA
49
3
SO
48
6
HPE
48
2
CVS
27
2
AON
25
4
IR
46
3
KIM
58
2
DIS
70
2
SCHW
40
3
ED
39
8
NKE
36
2
Financhill
Back

Endeavour Silver 10K Form

Sell
20

EXK
Endeavour Silver

Last Price:
$3.7100
Seasonality Move:
33.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EXK News And Ratings

See the #1 stock for the next 7 days that we like better than EXK

EXK Financial Statistics

Sales & Book Value

Annual Sales: $205.5M
Cash Flow: $-41.8M
Price / Cash Flow: 0
Annual Sales: $1.68
Price / Book: 2.36

Profitability

EPS (TTM): -0.13000
Net Income (TTM): $-29.5M
Gross Margin: $36.6M
Return on Equity: -7.37%
Return on Assets: -5.64%

Endeavour Silver Earnings Forecast

Key Endeavour Silver Financial Ratios

  • The Gross Profit Margin over the past 20 years for EXK is 17.82%.
  • The Selling, General & Administrative Expenses for EXK have been equal to 8.69% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 13.42% of Operating Income.
  • The Net Earning history of EXK is 2.98% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 10 years.

Endeavour Silver Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Metals & Mining
Sector: Materials
Current Symbol: EXK
CUSIP: 29258Y
Website: edrsilver.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 1.39
Quick Ratio: 1

Price-to-Earnings

Trailing P/E Ratio: 123.67
Forward P/E Ratio: 8.93

EXK Technical Analysis vs Fundamental Analysis

Sell
20
Endeavour Silver (EXK) is a Sell

Is Endeavour Silver a Buy or a Sell?

  • Endeavour Silver stock is rated a Sell
    The current Endeavour Silver [EXK] share price is $3.7100. The Score for EXK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.